Primary Adrenal Insufficiency during Immune Checkpoint Inhibitor Treatment: Case Reports and Review of the Literature

Simple item page
dc.coverageDOI: 10.1159/000507652
dc.creatorSalinas, Carlos
dc.creatorRenner, Alex
dc.creatorRojas, Carlos
dc.creatorSamtani, Suraj
dc.creatorBurotto, Mauricio
dc.date2020
dc.date.accessioned2025-11-18T19:45:32Z
dc.date.available2025-11-18T19:45:32Z
dc.description<p>As the indications and clinical use of immune checkpoint inhibitors increase, it is expected that we will face some of their less frequently reported complications. Primary adrenal insufficiency is one of them, and given its unspecific symptoms and potentially serious consequences, it is important to have a high degree of clinical suspicion. We present 3 cases and a review of the literature concerning its main clinical characteristics, diagnostics, and management.</p>eng
dc.identifierhttps://investigadores.uandes.cl/en/publications/226db4d0-4703-42e0-bac0-fbf5d312b68c
dc.identifier.urihttps://repositorio.uandes.cl/handle/uandes/54023
dc.languageeng
dc.rightsinfo:eu-repo/semantics/openAccess
dc.sourcevol.13 (2020) nr.2 p.621-626
dc.subjectImmune-related adverse events
dc.subjectIpilimumab
dc.subjectNivolumab
dc.subjectPrimary adrenal insufficiency
dc.titlePrimary Adrenal Insufficiency during Immune Checkpoint Inhibitor Treatment: Case Reports and Review of the Literatureeng
dc.typeArticleeng
dc.typeArtículospa
Files
Collections
PURE